These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 6212522)
1. [Perclusone ointment in the treatment of chronic rheumatoid arthritis. Experience with 78 patients]. Vachtenheim J Fysiatr Revmatol Vestn; 1982 Apr; 60(2):100-4. PubMed ID: 6212522 [No Abstract] [Full Text] [Related]
2. [Long-term therapy of rheumatoid arthritis with perclusone]. Rejholec V Z Rechtsmed; 1975; 34(5-6):141-8. PubMed ID: 132816 [TBL] [Abstract][Full Text] [Related]
3. [Perclusone in the treatment of inflammatory and degenerative diseases of the locomotor system]. Szulc EJ Wiad Lek; 1977 Feb; 30(2):93-5. PubMed ID: 138262 [No Abstract] [Full Text] [Related]
4. [Clinical result of the treatment of chronic rheumatoid arthritis by non-steroidal anti-inflammatory agent, clofezone. Comparative study with phenylbutazone in a double-blid study at several clinics]. Kageyama T Ryumachi; 1976 Mar; 16(1):85-99. PubMed ID: 135360 [No Abstract] [Full Text] [Related]
6. [Infulence of pyrasanone on the index of articular radioisotope (tc99m) uptake in rheumatoid arthritis]. Grimaldi MG; Bonora R Minerva Med; 1975 Sep; 66(56):2781-5. PubMed ID: 1174381 [TBL] [Abstract][Full Text] [Related]
7. [Aspirin-butadione electrophoresis in the treatment of patients with rheumatoid arthritis]. Kozlova LA; Tereshina LG Vopr Kurortol Fizioter Lech Fiz Kult; 1990; (3):21-3. PubMed ID: 2219811 [No Abstract] [Full Text] [Related]
8. A double-blind comparison of phenylbutazone and suxibuzone, a prodrug of phenylbutazone, in rheumatoid arthritis. Mizushima Y; Shiokawa Y; Honma M; Kageyama T Int J Tissue React; 1983; 5(1):35-9. PubMed ID: 6345427 [TBL] [Abstract][Full Text] [Related]
9. Clinical experience with phenylbutazone vials in venous perfusion. Pelliccioni S Minerva Ortop; 1971 Dec; 22(12):486-90. PubMed ID: 5135056 [No Abstract] [Full Text] [Related]
10. [Ranoroc in the treatment of degenerative joint and spinal diseases]. Bantz W Med Welt; 1980 Nov; 31(45):1636-8. PubMed ID: 6893852 [No Abstract] [Full Text] [Related]
11. Assessment of enteric-coated phenylbutazone in general practice. Rushford WA; Fowler PD Practitioner; 1970 Nov; 205(229):671-6. PubMed ID: 4923894 [No Abstract] [Full Text] [Related]
12. [Experience with a combination of phenylbutazone, isopyrin and prednisolone in the treatment of rheumatoid arthritis]. Rau R Med Welt; 1969 Sep; 36():1976-81. PubMed ID: 5809876 [No Abstract] [Full Text] [Related]
13. [Clinical evaluation of a new phenylbutazone-based compound]. Chériè Lignière G; Guastalla A Reumatismo; 1968; 20(4):279-83. PubMed ID: 5738056 [No Abstract] [Full Text] [Related]
14. The use of thermography in the evaluation of the anti-inflammatory activity of feprazone on rheumatoid arthritis. Singer F; Gruber J; Graber J; Reinthaler M; Thumb N Arzneimittelforschung; 1982; 32(4):427-9. PubMed ID: 7201815 [TBL] [Abstract][Full Text] [Related]
15. [Assessment and testing of the effect and tolerance of Perclusone Salbe (author's transl)]. Koudela K; Mráz L Acta Chir Orthop Traumatol Cech; 1981 Aug; 48(4):349-53. PubMed ID: 6457493 [No Abstract] [Full Text] [Related]
16. [Comparative studies on the bioavailability of various drug forms of phenylbutazone and clofezone (Perclusone)]. Reinicke C; Helbing M; Klingenfeld U; Lasaroff I; Wessel G Pharmazie; 1984 Dec; 39(12):824-7. PubMed ID: 6241720 [TBL] [Abstract][Full Text] [Related]